Pharmacologic Substance
promegapoietin
[ proh-meh-guh-poy-eh-tin ]
Definitions related to promegapoietin:
-
A drug given during chemotherapy to increase blood cell regeneration. Promegapoietin is a colony-stimulating factor that stimulates the production of blood cells, especially platelets. It is a cytokine and belongs to the family of drugs called hematopoietic (blood-forming) agents.NCI Dictionary of Cancer TermsU.S. National Cancer Institute, 2021
-
Any one of the family of genetically engineered chimeric molecules with strong activity in promoting megakaryocyte development. Promegapoietin consists of a truncated or modified interleukin-3 (IL-3) peptide, via a hinge peptide sequence from IgG, linked to multiple repeats of modified thrombopoietin (c-Mpl ligand). This agent is capable of activating megakaryocyte progenitor cells into producing platelets mediated through either IL-3 receptor or Mpl receptor.NCI ThesaurusU.S. National Cancer Institute, 2021
Return to OpenMD Medical Dictionary
> P
This content should not be used in place of medically-reviewed decision support reference material or professional medical advice. Some terms may have alternate or updated definitions not reflected in this set. The definitions on this page should not be considered complete or up to date.